TELCOMET 50 – Telmisartan & Metoprolol Succinate Extended-Release Tablets

What is TELCOMET 50?

TELCOMET 50 combines Telmisartan IP 40mg and Metoprolol Succinate USP 47.5mg (equivalent to 50mg Metoprolol Tartrate) formulated for extended release to effectively manage hypertension and cardiovascular conditions.

Composition

• Telmisartan IP 40mg

• Metoprolol Succinate USP 47.5mg (ER)

Strength & Formulation

Extended-release form ensures gradual and steady release over 24 hours.

Key Features of TELCOMET 50

Combination Therapy Benefits

The synergistic action of an angiotensin II receptor blocker and a beta-blocker provides comprehensive blood pressure control.

Extended-Release Technology

Ensures a steady release of Metoprolol Succinate for consistent therapeutic effect.

Quality & Safety Standards

Manufactured under strict international quality norms by Amcare Biosciences.

Indications & Benefits

Hypertension Management

Helps reduce and stabilize high blood pressure.

Cardiovascular Protection

Supports heart function and reduces long-term risks.

Why Choose TELCOMET 50 by Amcare Biosciences?

Amcare Biosciences is a reliable pharmaceutical manufacturer and exporter with advanced facilities focused on delivering high-quality formulations.

WHO-GMP Certified Manufacturing

Ensures global-standard production quality.

Trusted Export Capability

Delivers safe and effective medicines to international markets.

Packaging Details

Alu-Alu Blister Pack Advantages

Provides excellent protection from moisture, heat, and light, ensuring drug stability.